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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYBrown adipocytes (BAs) play important roles in body temperature regulation, energy balance, and carbohydrate and lipid metabolism.
Activities of BAs are remarkably diminished in obese and diabetic patients, providing possibilities of transplanting functional BAs result-
ing in therapeutic benefit. Here, we show generation of functional BAs by cellular reprogramming procedures. Transduction of the
PRDM16 gene into iPSC-derived embryoid bodies induced BA phenotypes (iBAs). Moreover, normal human fibroblasts were directly con-
verted into BAs (dBAs) by C/EBP-b and C-MYC gene transduction. Approximately 90% of the fibroblasts were successfully converted
within 12 days. The dBAs were highly active in mitochondrial biogenesis and oxidative metabolism. Mouse dBAs were induced by
Prdm16, C/ebp-b, and L-myc genes, and after transplantation, they significantly reduced diet-induced obesity and insulin resistance in
an UCP1-dependent manner. Thus, highly functional BAs can be generated by cellular reprogramming, suggesting a promising tailor-
made cell therapy against metabolic disorders including type 2 diabetes mellitus.INTRODUCTION
Brown adipocytes (BAs) have unique roles in energy expen-
diture and non-shivering thermogenesis, which is contrary
to white adipocytes (WAs) that store excess energy ob-
tained from food in the form of lipids (Gesta et al., 2007;
Chechi et al., 2013). The BAs specifically express uncou-
pling protein 1 (UCP1) at the mitochondrial inner mem-
brane to dissipate the electrochemical proton gradient as
heat, playing a pivotal role in regulation of body tempera-
ture, energy balance, and adiposity. In rodents, BAs prevent
diet-induced obesity, insulin resistance, and type II dia-
betes (Kontani et al., 2005). Until recently, however, the
significance of BAs in human remained controversial,
because BAs are rarely detectable in the adult human. Since
2009, positron emission tomography (PET) using 18F-fluo-
rodeoxyglocose (FDG) has clearly visualized metabolically
active brown adipose tissue (BAT) in supraclavicular, medi-
astinal, paravertebral, and perirenal regions characterized
by robust uptake of 18F-FDG upon acute cold exposure
(Saito et al., 2009; van Marken Lichtenbelt et al., 2009;
Cypess et al., 2009). Interestingly, the BA activity consider-
ably varies from person to person and correlates inversely
with age, fasting plasma glucose levels, and BMI (Saito
et al., 2009; Ouellet et al., 2011, 2012). These findings
strongly suggest the importance of BAs in physiological
regulation of the whole-body energy balance and body
fat accumulation, as well as the pathophysiology of obesity
andmetabolic diseases in humans. If human BAs with high
energy expenditure activity can be artificially generated,
the technology may greatly facilitate basic as well asStem Cellapplied research of these BAs. Especially, transplantation
of such BAs may provide a regenerative therapy to control
metabolic diseases, including diabetes mellitus.
Yamanaka’s group demonstrated that mammalian
somatic cells can be reprogrammed into induced pluripo-
tent stem cells (iPSCs) with embryonic-stem-cell-like
characteristics by transducing genes for transcription fac-
tors, Octamer-binding transcription factor 3/4 (OCT4), SOX2,
KLF-4, and C-MYC (so called reprogramming factors; Taka-
hashi andYamanaka, 2006; Takahashi et al., 2007), strongly
suggesting that a small number of key transcription factors
may globally change epigenetic programming in somatic
cells to convert their fates (Meissner, 2010; Papp and Plath,
2011). More recently, somatic cells were redirected into
another differentiated cell lineage, without passing an
intermediate pluripotent stage, by transducing a set of
transcription factors that play crucial regulatory roles in
the differentiation of the destination cell; direct conver-
sion, or direct reprogramming, of murine fibroblasts into
cardiomyocytes (Ieda et al., 2010; Inagawa et al., 2012; Ina-
gawa and Ieda, 2013), neurons (Kim et al., 2011, 2012;
Caiazzo et al., 2011; Han et al., 2012), chondrocytes (Hira-
matsu et al., 2011), and hepatocytes (Sekiya and Suzuki,
2011; Huang et al., 2011), as well as of human fibroblasts
into cardiomyocytes (Wada et al., 2013; Nam et al., 2013),
neurons (Pang et al., 2011; Caiazzo et al., 2011; Kim et al.,
2012), and hematopoietic cells (Szabo et al., 2010) have
been reported. Although the efficiencies of direct conver-
sion were generally low (0.005%–30% of fibroblasts were
successfully converted into the cells of interest; Thier
et al., 2012; Sekiya and Suzuki, 2011; Pang et al., 2011;Reports j Vol. 5 j 569–581 j October 13, 2015 j ª2015 The Authors 569
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Figure 1. Human iBAs Induced from iPSCs
(A and B) Human iPSCs were cultured in the
presence of RA followed by transduction with
PRDM16 retroviral vector. After culturing for
12 days, cells were subjected to Oil Red O and
mitochondrial staining (A), as well as immu-
nostaining with the indicated antibodies (B).
Original magnification was 1003.
(C) Real-time RT-PCR was performed to eval-
uate mRNA levels of the indicated genes in
HDFs and hiBAs.
(D) Human dermal fibroblasts (HDFs) and
human iBAs were stimulated with the indi-
cated concentrations of isoproterenol.
Twelve hours later, UCP1 mRNA levels were
evaluated by real-time RT-PCR.
(E) Oxygen consumption of the indicated
cells was evaluated. Oligomycin (O), FCCP (F),
and antimycin A and rotenone (A + R) were
serially added to the culture at the indicated
time periods.
In (A)–(E), n =3 cultures per group. In (C) and
(D), values (average ± SD) were normalized
to b-ACTIN mRNA and expressed relative to
values for the HDFs (set to 1.0; n = 3 cultures
per group). In (E), values are average ± SD
(n = 3 cultures per group). The experiments
were repeated more than three times.Nam et al., 2013; Kim et al., 2011, 2012; Inagawa et al.,
2012; Inagawa and Ieda, 2013; Ieda et al., 2010; Huang
et al., 2011; Han et al., 2012; Caiazzo et al., 2011), these
technologies may be quite valuable for generation of the
desired cells that could be used in basic research as well as
in regenerative therapy for various human disorders. We
have recently succeeded in directly reprogramming human
fibroblasts into osteoblasts that massively produced bone
matrix and contributed to bone regeneration with an effi-
ciency as high as 80% (Yamamoto et al., 2015).
In the current study, we directed our efforts to generate
BAs from iPSCs and fibroblasts by introducing the genes
that play central roles in BA development as well as in so-
matic cell reprogramming and analyzed their functions in
culture and transplanted animals.RESULTS
iBAs Induced from iPSCs Suppressed Obesity and
Diabetes
Human iPSCs were cultured with retinoic acid (RA) at
doses of 25 mM (initial 7 days) and 50 mM (next 10 days),
followed by transduction of the gene encoding the
PRDM16 (PRD1-BF1-RIZ1 homologous domain containing
16) that was reported as the key regulator of BA differenti-570 Stem Cell Reports j Vol. 5 j 569–581 j October 13, 2015 j ª2015 The Aation (Seale et al., 2007, 2008). After culturing for another
12 days, approximately 75% of the cells showed BA-like
appearance characterized by multilocular lipid droplets
and abundant mitochondria (Figure 1A). The cells highly
expressed UCP1, CIDEA, and DIO2 genes that are known
to be specifically expressed in BAs (Figures 1B and 1C).
Stimulation of these cells (namely iBAs) with isoproterenol,
a general agonist of b-adrenergic receptors, resulted in
further elevation of expression level ofUCP1mRNA, which
is a typical adrenergic response of BAs (Figure 1D). The hu-
man iBAs showed remarkably high rates of oxygen con-
sumption and uncoupling respiration (Figure 1E).
We obtained mouse iBAs as above and assessed their
metabolic activities in vitro and in vivo. The mouse iBAs
expressed Ucp1 and Cidea mRNA at comparable levels to
those in the BAT (Figure S1A). They were rich in lipid de-
posits and mitochondria (Figure S1B) and showed a high
rate of uncoupling respiration (Figure S1C). The iBAs were
subcutaneously transplanted into syngenic mice, and their
heat-producing activity was measured. As shown in Fig-
ure 2A, cold exposure resulted in heat production at site
of the graft. Histological examinations revealed the pres-
ence of Oil Red O-positive iBAs in the graft (Figure 2B).
The mice transplanted with iBAs were given a high-fat
diet. A shown in Figure 2C, they gained body weight less
significantly than controls. Serum lipid analyses indicateduthors
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Figure 2. iBAs Suppressed Diet-Induced Obesity and Diabetes in Mice
(A and B) C57BL/6 mice were subcutaneously transplanted with syngenic iBAs or control cells that had not been transduced with Prdm16
(d0). Two weeks after the transfection, thermographic images of mice were captured after exposure to 4C for 2 hr (A). Mice were then
sacrificed, and graft tissue sections were stained with Oil Red O (B; original magnification was 403).
(C and D) C57BL/6 mice were subcutaneously transplanted with syngenic iBAs or GFP-transduced cells as control and housed on either
standard- or high-calorie diet. Body weights of mice were measured (C), and serum lipid concentrations were determined 4 weeks after
transplantation (D).
(E–H) KK-Ay diabetic mice were subcutaneously transplanted with syngenic iBAs or GFP-transduced fibroblasts as a control. Body weights
(E) and non-fasting serum glucose levels (F) of the mice are shown. Urine glucose levels were measured 3 weeks after the transplantation
(G), and serum lipid concentrations were determined 4 weeks after the transplantation (H).
In (C)–(H), values are average ± SD (n = 8 mice per group) for one out of two independent experiments. *p < 0.05 (two-sided Student’s
t test). In (A) and (B), n = 3 mice per group. The experiments were repeated more than twice. See also Figures S1 and S2.that the dyslipidemia caused by high-calorie diet was signif-
icantly restored by the iBA transplantation (Figure 2D).
Next, experiments were performed to confirm the effect
of iBAs on metabolic aberration using a different mouse
model, i.e., type 2 diabetic KK-Ay mice (Kennedy et al.,
2010; Tomino, 2012; O’Brien et al., 2013). iPSCswere estab-
lished from fibroblasts of KK-Ay mice (Figure S2), and iBAs
induced from the iPSCs were transplanted into syngenic
hosts. As shown in Figures 2E and 2F, the iBA-transplanted
mice showed significantly lower body weight gain andStem Cellserum glucose elevation. The iBA transplantation also
reduced urine glucose (Figure 2G) and serum levels of total
cholesterol, LDL cholesterol, triglycerides (TGs), phospho-
lipid, and non-esterified fatty acids (NEFA) (Figure 2H).
Although HDL cholesterol level was not significantly
affected, the ratio of HDL/total cholesterol was remarkably
increased by the iBA transplantation (Figure 2H).
These results demonstrated that iBAs were metabolically
active in vivo and significantly suppressed diet-induced
obesity, dyslipidemia, and type 2 diabetes.Reports j Vol. 5 j 569–581 j October 13, 2015 j ª2015 The Authors 571
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Figure 3. Human Dermal Fibroblasts Were Efficiently Converted into BAs by Defined Factors
(A and B) HDFs were transduced with the indicated retroviral vectors, and after culturing for 12 days, cells were subjected to mitochondria
staining (A) and Oil Red O staining (B). Original magnification was 1003.
(C) HDFs transduced with C and/or M retrovirus vectors were cultured for 14 days, and mRNA levels for the indicated genes were evaluated
by real-time RT-PCR.
(D) CM-transduced HDFs were cultured for 12 days and immunostained with the indicated antibodies (original magnification was 1003;
immunostaining images were obtained using haze reduction). In (A) and (D), representative images of three independent experiments
(n = 3 cultures per group) are shown.
(E) CM-transduced HDFs and untransduced HDFs were cultured for 12 days and stained with DAPI (nuclear staining) and anti-UCP1
antibody as above. Proportions of UCP1-staining cells are shown as average ± SD (representative of three independent experiments; n = 3
cultures per group).
(F) RNA was obtained from HDFs, iBAs, and CM-infected HDFs cultured for 12 days (dBAs). Relative mRNA levels for the indicated genes
were evaluated.
In (C) and (F), values (average ± SD) were normalized to b-ACTIN mRNA and expressed relative to values for the HDFs (set to 1.0). The
experiments were repeated more than three times. See also Figures S3 and S4.Direct Conversion of Fibroblasts into BAs
We next tried to directly convert human fibroblasts into
BAs. Retroviral vectors containing the PRDM16 (P) and
C/EBP-b (C) genes, as well as those containing the reprog-
ramming factor genes (Klf4 [K], L-MYC [L], C-MYC [M],
and Glis1 [G]) were prepared, and various combinations
of the retroviral vectors were infected into dermal fibro-
blasts. Oil Red O staining suggested that some combina-572 Stem Cell Reports j Vol. 5 j 569–581 j October 13, 2015 j ª2015 The Ations of genes, such as PCLMG, CLMG, PCLM, CLM, and
CM, strongly evoked fibroblasts to accumulate lipid drop-
lets (Figure S3A).
Thus, we transduced PRDM16, C/EBP-b, and/or C-MYC
genes to the cells and examined the efficiency of induction
of BA-like characteristics in more detail. The results are
shown in Figures 3A and 3B. Oil Red O-positive lipid drop-
lets were only faintly induced in C- and PC-transduceduthors
cells. Meanwhile, the PCM mixture more drastically
induced accumulation of the lipid depots and an increase
in number of mitochondria in the cells. Interestingly, the
combination CM converted fibroblasts into cells with a
BA-like phenotype at the highest rate.
Cells transduced with C and/or M were tested for mRNA
expression of endogenous PRDM16, C/EBP-b, and C-MYC
genes. Exogenous C/EBP-b induced endogenous C/EBP-b,
whereas both C/EBP-b and C-MYC were required for induc-
tion of PRDM16 (Figure 3C). Thus, CM transduction
induced endogenous C/EBP-b and PRDM16 gene expres-
sion, which may have caused conversion of fibroblasts
into BA-like cells. Fibroblasts expressed endogenous c-myc
mRNA at low level, which was not affected by transduction
with C and/or M.
The CM-transduced cells were referred to as directly con-
verted BAs (dBAs) and examined in more detail. Immuno-
staining showed that the dBAs highly expressed BA-specific
proteins (Figure 3D). It was found that 92.1% ± 12.1% of
the fibroblasts became UCP1-positive cells (Figure 3E).
The cells expressed mRNA for UCP1, CIDEA, and ADIPOQ
at extremely high levels compared with fibroblasts. The
mice BAT expressed comparable levels of mRNA for these
genes (Figure 3F).
We also performed DNA microarray analysis to examine
genome-wide mRNA expression profiles. Hierarchical clus-
tering analysis revealed that gene expression profile of
dBAs was closer to that of iBAs than those of fibroblasts
and WAs (Figures 4A and 4B).
We analyzed the effects of CM transduction on the
epigenetic status of BA-related genes. In untransduced
fibroblasts, genomic DNA was heavily methylated at CpG
dinucleotides at the upstream regions of the PPARg
(peroxisome proliferator-activated receptor-g) and UCP1 gene
loci. In sharp contrast, the CpG sequences were mostly un-
methylated 12 days after CM transduction (Figure 4C).
Functional features of the dBAs were assessed in vitro. As
shown in Figure 5A, the copy number of mitochondrial
DNA rapidly increased afterCM transduction of fibroblasts,
which was consistent with an increase in the number of
mitochondria (Figure 3A). Addition of leptin and isoproter-
enol prompted dBAs to highly express mRNA for UCP1 and
the leptin receptor (LEPR) (Figures 5B and 5C). dBAs
consumed more glucose than fibroblasts, as indicated by
the decrease in glucose content in the culturemedium (Fig-
ure 5D) and uptake of 2-deoxy glucose (2DG) (Figure 5E).
The glucose uptake by dBAs was further elevated after stim-
ulation with insulin, which in turn could be inhibited by
phloretin, an inhibitor of the glucose transporter, and anti-
mycin, a suppressor of the electron transport chain. dBAs
also showed a higher rate of oxygen consumption than fi-
broblasts (Figure 5F). The oxygen uptake of dBAs was only
partially suppressed by oligomycin, an inhibitor of mito-Stem Cellchondrial ATP synthase, demonstrating a high rate of un-
coupling respiration. It is virtually impossible to obtain
viable BAs from human BAT and culture them for func-
tional analyses; therefore, metabolic activity of human
BAs has not been fully evaluated. Our results indicated
that human dBAs were highly active in mitochondrial
biogenesis and oxidative metabolism.
We examined whether dBAs were actually converted
from fibroblasts without passing an immature pluripotent
stage. After transduction with CM, fibroblasts were immu-
nostained with anti-NANOG antibody every day during
days 1–5 post-transduction. No significant expression of
NANOG, which is an essential transcription factor for
pluripotent cells, was detected at all during the experi-
mental periods, whereas UCP1 was detected as early as
day 5 (Figure S3B). These results suggest that dBAs were
directly converted from fibroblasts.
The dBAs expressed retroviral C/EBP-b and C-MYC trans-
genes at high levels (Figure S4A). We assessed whether
continuous expression of these exogenous genes is
required for dBAs to maintain their phenotype. Using the
Tet-On promoter system, fibroblasts were allowed to ex-
press retroviral C and M genes only during the first
20 days, followed by culturing for another 22 days without
induction of the exogenous gene expression. Because the
Tet-On promoter achieved relatively low levels of expres-
sion of C andM genes even in the presence of doxycycline,
efficiency of conversion was lower than that obtained by
conventionalCM retrovirus vectors; thus, we picked up col-
onies with lipid droplets for qRT-PCR analysis. As results,
the cells retained the BA-like character on day 42 (Figures
S4B and S4C), although they no longer expressed exoge-
nous C andM genes (Figure S4A). Therefore, dBAs, once es-
tablished by transient CM expression, may have developed
intrinsic program that stably maintained the dBA pheno-
type even in the absence of the exogenous gene expression.
We tried to convert mouse fibroblasts into dBAs. Interest-
ingly, transduction of CM that successfully converted hu-
man fibroblasts into dBAs failed to significantly induce
Ucp1 mRNA in MEFs (mouse embryonic fibroblasts) per
se, whereas PCL was found the most-effective gene combi-
nation for mouse dBA direct reprogramming (Figure S5A).
Transduction of CM and CL induced expression of
PRDM16 in human (Figures 3B and S5B, lower), but not
mouse (Figure S5B, upper), fibroblasts, which may be the
reason why exogenous Prdm16 is required for the conver-
sion of mouse fibroblasts into dBAs. The PCL-transduced
cells (mouse dBAs) expressed Ucp1 and Cidea mRNA as
strongly as mouse BAT (Figure S5C) and shared similar
gene expression profiles with mouse BAT, but not with
MEFs (Figure S5D). Themouse dBAs also showed high rates
of basal oxygen consumption and uncoupling respiration
(Figure S5E).Reports j Vol. 5 j 569–581 j October 13, 2015 j ª2015 The Authors 573
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Figure 4. Characterization of dBAs
HDFs were transduced with CM retroviruses as in Figure 3D, and after culturing for 12 days, the cells were uses as dBAs.
(A and B) RNA was extracted from HDFs, WAs, iBAs (obtained from two independent induction experiments), and dBAs (obtained from
three independent induction experiments). DNA microarray analyses were performed. Heatmap and correlation coefficient values for all
genes are shown (A). Among 29,096 genes tested, 3,517 genes were shown differentially expressed among the cells (greater than three
folds), and heatmap and hierarchical clustering analysis of the differentially expressing genes are shown (B). Red and blue colorations
indicate increased and decreased expression, respectively.
(C) Genomic DNA was extracted from HDFs and human dBAs and tested for CpG methylation at the PPAR-g and UCP1 gene upstream regions
(n = 10 plasmid clones per group). The experiments were repeated more than three times.
See also Table S2.dBAs Significantly Improved Metabolic Traits In Vivo
Mouse dBAs were subcutaneously transplanted into syn-
genic mice, and high-fat diet was given to them. The diet-
induced obesity was remarkably prevented by the dBA
transplantation (Figure 6A). Glucose tolerance and insulin
sensitivity were significantly improved as early as 2 weeks
after the dBA transplantation (Figure 6B), when body574 Stem Cell Reports j Vol. 5 j 569–581 j October 13, 2015 j ª2015 The Aweights of mice did not significantly differ among groups
(Figure 6A), strongly suggesting that the improvement in
glucose tolerance and insulin sensitivity was not second-
arily resulted from the suppression of body weight gain.
Serum lipid analyses indicated that dBA transplantation
reduced total cholesterol, LDL cholesterol, TG, phospho-
lipid, and NEFA levels and significantly elevated theuthors
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Figure 5. Metabolic Features of dBAs
(A) DNA was extracted from CM-transduced HDFs on the indicated days after transduction. Relative copy number of MT-ND1 was determined
by real-time PCR.
(B and C) Cells were stimulated with 100 nM leptin for 6 hr or 1 mM isoproterenol for 2 hr. mRNA for UCP1 (B) and LEPR (C) genes were
evaluated.
(D) HDFs, dBAs, and dBAs pre-stimulated with isoproterenol were cultured for 24 hr. Glucose content in the supernatant was determined.
(E) Cells were cultured with or without insulin, whereas some cell aliquots were also treated with the indicated reagents. Thirty minutes
after addition of 2DG, incorporated 2DG was evaluated.
(F) Oxygen consumption of the indicated cells was evaluated as in Figure 1E.
Values in (A)–(F) are average ± SD (n = 3 cultures per group). The experiments were repeated more than three times.HDL/total cholesterol ratio (Figure 6C). The graft area
showed high temperature (Figure 6D), suggesting that the
dBAsmayhave expended the dietary energy as heat. Immu-
nohistochemical analysis of graft tissue demonstrated
tyrosine hydroxylase-positive cells (Figure S6A), strongly
suggesting sympathetic innervation of the dBA graft.
Finally, we investigated whether dBA transplantation
affected insulin resistance and dyslipidemia in type 2 dia-
betes. KK-Ay diabeticmice were transplantedwith dBAs ob-
tained from syngenic MEFs. The mice showed significantly
lower body weight gain (Figure 7A) and serum glucose
levels (Figures 7B and 7C) compared with controls. The
glucose tolerance of diabetic mice was significantly
improved by the dBA transplantation, which also reduced
insulin resistance (Figures 7D and 7E). Serum levels of total
cholesterol, LDL cholesterol, TG, phospholipid, and NEFA
were reduced by the dBAs as well (Figure 7F).
In an attempt to clarify the mechanism of suppression of
insulin resistance by dBAs, some mice were grafted with
dBAs that had been transfected with shRNA specific forStem CellUcp1. The shRNA treatment suppressed Ucp1 mRNA to
approximately 14% (Figure S6B). As result, the silencing
of Ucp1 significantly cancelled the effects of dBAs on
body weight gain (Figure 7A), serum glucose levels (Figures
7B and 7C), glucose tolerance (Figure 7D), and dyslipide-
mia (Figure 7F).DISCUSSION
Two different lineages of BAs have been known. Classical
BAs are derived from Myf-5 expressing common progeni-
tors formyoblasts and BAs (Seale et al., 2008). Themyoblas-
tic precursors originate from the mesenchymal stem cells
(MSCs). PRDM16 is crucially involved in the differentiation
of myoblasts into classical BAs (Seale et al., 2007, 2008;
Kajimura et al., 2009). PRDM16 interacts with C/EBP-b to
form an active transcription complex that enhances
expression of genes involved in brown adipogenesis, such
as PGC-1a (Kajimura et al., 2009). Ahfeldt et al. (2012)Reports j Vol. 5 j 569–581 j October 13, 2015 j ª2015 The Authors 575
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Figure 6. dBAs Suppressed Diet-Induced Obesity in Mice
C57BL/6 MEFs were transduced with either PCL or GFP retroviral vectors (day 12), and the resultant cells (dBAs and GFP control,
respectively) were subcutaneously transplanted into syngenic mice (day 0). These mice, as well as non-transplanted mice, were housed on
either standard- or high-calorie diet.
(A) Body weights of the mice are shown.
(B) Two and four weeks after transplantation, oral glucose tolerance test (upper) and insulin resistance test (lower) were performed.
(C) Serum lipid concentrations on day 28 are shown. Values are average ± SD for one out of two independent experiments (n = 8 mice per
group). *p < 0.05 (two-sided Student’s t test).
(D) Two weeks after transplantation, mice were exposed to 4C for 2 hr. Shown are thermographic images of the representative mice
(n = 4 mice per group). The experiments were repeated more than twice.
See also Figures S5 and S6A.induced human iPSCs to differentiate intoMSCs and subse-
quently transduced them with the PPAR-g2 and C/EBP-b
(with/without PRDM16) genes. The resultant cells ex-
pressed UCP1 approximately 20-fold higher than WAs
(Ahfeldt et al., 2012). Nishio et al. (2012) cultured human
iPSCs and ESCs with a cocktail of hematopoietins and suc-
ceeded in inducing the classical BAs. The cells improved
oral fat and glucose tolerance of normal mice 16 hr after
transplantation (Nishio et al., 2012). Our iBAs were
induced from iPSCs via a myoblast-like state, and only
PRDM16 was required for the conversion of the myoblast-
like cells into iBAs (Figure 1), which is consistent with
previous literature on the contribution of PRDM16 in
differentiation of classical BAs (Seale et al., 2007, 2008;
Kajimura et al., 2009).
Meanwhile, inducible BAs, also referred to as brite
(brown in white), beige, or brown-like adipocytes, are576 Stem Cell Reports j Vol. 5 j 569–581 j October 13, 2015 j ª2015 The Adirectly converted from MYF-5-negative adipocytes in
white lipid depots (Giralt and Villarroya, 2013; Lo and
Sun, 2013; Chechi et al., 2013). The induction of the
BA-like phenotype (browning) is caused by chronic cold
exposure, hormonal or b-adrenergic signals, or pharmaco-
logical activation of PPAR-g. Again, PRDM16 plays a crucial
role in the browning; it binds to CTBP1 (C-terminal-bind-
ing protein 1) andCTBP2 to repress transcription of various
WA-specific genes, whereas an association of PRDM16with
PGC-1a and PGC-1b results in induction of genes involved
in BA differentiation (Kajimura et al., 2008). It is also been
shown that the vascular endothelium of adipose tissue can
transdifferentiate into WAs and BAs (Tran et al., 2012).
Unlike these physiological differentiation pathways of
BAs, i.e., differentiation of classical BAs from MSCs via
myoblasts, and transdifferentiation of inducible BAs from
WAs, we succeeded in artificial conversion of unrelateduthors
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Figure 7. dBAs Suppressed Diabetes in Mice
KK-Ay MEFs were transduced with either PCL or GFP retroviral vectors (day 12) to obtain dBAs and GFP control cells, respectively. Other
cells were transduced with both PCL and shUCP1. The cells were subcutaneously transplanted into syngenic mice (day 0).
(A–C) Body weights of mice (A) as well as fasting and non-fasting serum glucose levels (B and C) of the mice are shown.
(D–F) On day 28, oral glucose tolerance test (D) and insulin resistance test (E) were performed, while serum lipid concentrations were
evaluated (F). Values are average ± SD (n = 8 mice per group). The experiments were repeated more than twice.
See also Table S3 and Figure S6B.somatic cells into highly functional BAs. In a previous
report, not only myoblasts but also immortalized and
normal fibroblasts were co-transduced with PRDM16 plus
C/EBP-b genes (Kajimura et al., 2009). After the transduc-
tion, the immortalized mouse fibroblasts expressed Ucp1
mRNA approximately 1,000-fold higher than untrans-
duced cells, whereas normal human and mouse fibroblasts
had approximately 7 and 20 times higher expression levels
than untransduced ones, respectively. Mouse BAT ex-
presses approximately 200,000 times higher Ucp1 mRNA
compared with fibroblasts that express this gene very
faintly (Figure 3F). Our experiments also showed that
PRDM16 plus C/EBP-b (PC) very faintly induced the BA-like
phenotype in human fibroblasts (Figures 3A and 3B). In
contrast, the dBAs induced byC/EBP-b andC-MYC (CM) ex-
pressed UCP1 mRNA approximately 100,000-fold higher
than untransduced fibroblasts (Figure 3F) and showed aStem Cellmuch more significant BA-like phenotype than PC-trans-
duced cells (Figures 3A and 3B). Thus, C-MYC must have
played an indispensable role in the reprogramming of
normal fibroblasts into fully functional dBAs. C-MYC is
one of the Yamanaka’s reprogramming factors (Takahashi
and Yamanaka, 2006; Takahashi et al., 2007), and although
it is not a prerequisite for iPSCs generation (Nakagawa
et al., 2008), C-MYC is shown to play important roles in
direct reprogramming of mouse fibroblasts into neural
stem cells (Han et al., 2012; Thier et al., 2012) and chondro-
cytes (Hiramatsu et al., 2011). In our procedure, C-MYC
induced PRDM16 gene in cooperation withC/EBP-b, which
may be crucial for reprogramming of fibroblasts into dBAs
(Figure 3C).
The present study showed that transplantation of
iBAs and dBAs markedly reduced diet-induced obesity,
dyslipidemia, and insulin resistance in mice (Figures 2, 6,Reports j Vol. 5 j 569–581 j October 13, 2015 j ª2015 The Authors 577
and 7). The dBAs controlled insulin resistance in an
UCP1-dependent fashion, strongly suggesting the UCP1-
mediated energy expenditure as the principal mechanism
underlying the control of insulin resistance (Figure 7).
Gunawardana and Piston (2012) transplanted BAT from
mouse embryos into type 1 diabetic mice and showed sig-
nificant suppression of diabetic markers. Stanford et al.
(2013) transplanted BAT from the interscapular region of
adult mice into syngenic mice and found significant
improvement in the high-calorie-diet-associated metabolic
traits. The present study demonstrated artificial generation
of highly functional BAs capable of controlling insulin
resistance, dyslipidemia, and obesity.
The present study suggests the possibility of a cell ther-
apy for the metabolic diseases using tailor-made BAs.
Such regenerative therapies may be particularly efficacious
to those patients whohave lost functional BAT due to aging
and/or progression of metabolic diseases (Saito et al., 2009;
Ouellet et al., 2011).EXPERIMENTAL PROCEDURES
Cells
aHDF (normal human dermal fibroblasts) was purchased fromKur-
abo (cat no. KF-4109), whereas the PLAT-GP and PLAT E packaging
cell lines were purchased from Cell Biolabs (cat nos. VPK-305 and
VPK-303, respectively). They were cultured in Dulbecco’s modified
eagle medium (DMEM) (Nacalai Tesque) supplemented with 10%
FBS, 100 mM non-essential amino acids (NEAA), 100 U/ml peni-
cillin, and 100 mg/ml streptomycin (Complete medium). SNL
feeder cells were purchased from DS Pharma Biomedical (cat no.
EC07032801-F0). Human iPSCs were established from NHEK (hu-
man epidermal keratinocytes; cat no. FC-0025; Kurabo) by trans-
fecting Epstein-Barr virus (EBV)-based episomal vectors encoding
OCT3/4, KLF-4, SOX2, C-MYC, and LIN28 as described (Takahashi
et al., 2007). KK-Ay mouse iPSCs were established from tail tip
fibroblasts by transduction with retroviral vectors containing
murine Oct3/4, Klf-4, Sox2, and C-myc genes (Figure S3). Every
cell line had been determined to be negative for mycoplasma
contamination.
Retroviral Vectors
The coding sequences for human PRDM16 and C/EBP-b genes
(DNAFORM cDNA clone library; DNAFORM) were amplified by
RT-PCR and cloned into EcoRI-digested pMXs vector (Cell Biolabs).
pMXs vectors containing human Krueppel-like factor 4 (KLF4), Glis
family zinc finger 1 (GLIS1), C-MYC, and L-MYC genes were a kind
gift of Professor S. Yamanaka (Kyoto University). PLAT-GP pack-
aging cells (5.5 3 106) were plated on geratin-coated 10-cm dishes
and cultured overnight. They were co-transfected with pCMV-
VSV-G and one of the pMX plasmids containing transcriptional
factor genes as above using the X-treme Gene 9 transfection re-
agent (Roche Applied Science) diluted in Opti-MEM. Twenty-four
hours later, the culture supernatant was replaced by anti-biotic
free culture medium. After culturing for another 24 hr, the super-578 Stem Cell Reports j Vol. 5 j 569–581 j October 13, 2015 j ª2015 The Anatant was collected and filtered through a 0.45-mm pore-size
filter. The coding sequences for mouse Prdm16 and C/ebp-b genes
(DNAFORM) were amplified by RT-PCR. Ecotrophic retroviral
vectors were constructed as above, except that PLAT-E packaging
cells were used instead of PLAT-GP. The GFP retroviral vector was
kindly provided by Professor S. Yamanaka of Kyoto University.
Induction of BAs from iPSCs
Human iPSCs were induced to differentiate into embryoid
bodies by culturing in DMEM medium supplemented with 10%
FBS and 25 mM RA in nonadherent culture dishes. On day 7, cells
were collected, allowed to adhere to plastic dishes, and cultured
for another 10 days in DMEM supplemented with 10% FBS and
50 mM RA. Cells were then transduced with the retroviral vector
encoding human PRDM16, followed by further culturing in BA1
medium (10% FBS, 0.5 mM 3-isobutyl-1-methylxantine [IBMX],
1 mM dexamethasone, 125 nM indomethacin, 850 nM insulin,
1 nM triiodothyronine [T3], and 1 mM rosiglitazone) for 2 days
and subsequently in BA2 medium (10% FBS, 850 nM insulin,
1 nM T3, and 1 mM rosiglitazone) for 8 days. Mouse iPSCs were
cultured in DMEM/10% FBS under nonadherent conditions. RA
was added to the culture medium to a final concentration of
25 mM (days 3–5) and 50 mM (days 5–7) to obtain embryoid bodies.
On day 7, cells were collected and cultured for another 10 days in
DMEMsupplementedwith 10% FBS and 50 mMRAunder adherent
conditions. The cells were transfectedwith an episomal vector con-
taining the mouse PRDM16 gene by electroporation, followed by
further culturing in BA1 medium for 2 days and in BA2 medium
for 8 days.
Direct Conversion of Fibroblasts into BAs
Human dermal fibroblasts (HDFs) were seeded onto culture dishes
or plates at a density of 1.5–2.0 3 104 cells/ml. On the next day,
cells were transduced with various combinations of retroviral
vectors (Figures 3A–3B, S3A, and S5) or a mixture of C/EBP-b and
C-MYC retroviral vectors (CM) (Figures 3C–3E, 4, 5, and S3B) in
the presence of 4 mg/ml polybrene (day 0). On day 1, culture super-
natant was replaced by fresh type 1 medium (10% FBS, 850 nM
insulin, 1 nM T3, 0.5 mM IBMX, 1 mM dexamethasone, 125 nM
indomethacin, and 1 mM rosiglitazone). After culturing for
2 days, culture supernatant was replaced by type 2 medium (10%
FBS, 850 nM insulin, 1 nM T3, and 1 mM rosiglitazone). Culture
medium was refreshed once every 2 days. MEFs derived from
C57BL/6 and KK-Ay mice were transduced with various combina-
tions of retroviral vectors (Figure S5A) or a mixture of Prdm16,
C/ebp-b, and L-myc retroviral vectors (PCL) (Figures 6, 7, and S5B–
S5E) as above.
Cell Staining
For mitochondrial staining, MitoTracker Red probe (Invitrogen)
was added to the culture to a final concentration of 200 nM and
cells were incubated at 37C in 5% CO2/95% humidified air for
15 min. For Oil Red O staining, cells were washed with PBS ()
and fixed with 60% isopropanol. After staining with the Oil Red
O solution (0.048% w/v Oil Red O in 60% isopropanol), cells
were washed with 60% isopropanol followed by washing with
distilled water.uthors
Immunostaining
The cells were fixed in 4% paraformaldehyde at 4C for 30 min.
After washing with PBS, the cells were stained with the following
antibodies, all at the optimally titrated dose. To stain human
UCP1 and DIO2, cells were incubated with goat anti-human
UCP1 (cat no. PAB6905; Abnoba) and goat anti-human DIO2
(cat no. NBP1-00178; Novus Biologicals), respectively, followed
by washing and incubation with secondary antibody (either
Alexa-488-labeled anti-goat IgG [cat no. A11070; Invitrogen] or
PE-labeled anti-goat IgG [cat no. PA1-29953; Thermo Scientific]
antibody). To stain human CIDEA, rabbit anti-human CIDEA
(cat no. NBP1-46987; Novus Biologicals) and Alexa-488-labeled
anti-rabbit Ig (cat no. A11070; Invitrogen) antibodies were
used. Human PGC1 was stained using rabbit anti-human PGC1
(cat no. NBP1-04676; Novus Biologicals) and PE Cy5-labeled
anti-rabbit IgG (cat no. sc-45110; Santa Cruz Biotechnology) an-
tibodies. To stain mouse UCP1, CIDEA, and DIO2, cells were
incubated with anti-mouse UCP1 (cat no. MAB6158; R&D Sys-
tems), rabbit anti-mouse CIDEA (cat no. PAB11960; Abnoba),
and goat anti-mouse DIO2 (cat no. NBP1-0017; Novus Biologi-
cals) antibodies, followed by staining with CF488-conjugated
anti-mouse IgG (cat no. 20014; Biotium), Alexa-488-labeled
anti-rabbit Ig (cat no. A11070; Invitrogen), and PE-conjugated
anti-goat IgG (cat no. sc45110; Santa Cruz Biotechnology) anti-
bodies, respectively.
Real-Time RT-PCR
Total RNAwas extracted from cells using ISOGEN II (NipponGene)
and reverse transcribed using ReverTra Ace qPCR RT Master Mix
(TOYOBO). In some experiments, dBAs were stimulated with
100 nM leptin for 24 hr or 1 ml isoproterenol for 2 hr before RNA
extraction. RNAwas also extracted fromBAT isolated from the pos-
terior cervical region of C57Bl/6 mice. Real-time RT-PCR was car-
ried out using Real-time PCRMaster Mix (TOYOBO) andmatching
probes and primers on a 7300 Real-Time PCR System (Applied Bio-
systems). All values were normalized with respect to the b-actin
mRNA level in each sample and expressed relative to the corre-
sponding value in gingival fibroblasts. The primer sequences are
shown in Table S1.
DNA Microarray Analysis
For human cells, RNAwas obtained fromWAs, iBAs, and dBAs, and
after reverse-transcription, microarray analyses were performed
using GeneChip human Gene 1.0 ST (Affymetrix) according to
the manufacturer’s instruction. For mouse cells, RNA obtained
from MEFs, BAT, and dBAs was reverse-transcribed and analyzed
using GeneChip Mouse Genome 430 2.0 Array. Scanned data
were analyzed using Expression Console (Affymetrix) and Gene-
Spring Ver.12.6 (Agilent Technologies) software.
Bisulfite Sequencing
Bisulfite treatment of genomic DNA was performed using Methyl-
Code Bisulfite Conversion Kit (Invitrogen), according to the
manufacturer’s instruction. The sequences corresponding to the
human UCP-1 gene upstream region (693 to 348 bases relative
to the transcription start site) and the PPARg gene upstream region
(431 to 151 bases relative to the transcription start site) wereStem Cellamplified by PCRusing primers described in Table S2. The resultant
PCR product was cloned into the pTA2 vector (TOYOBO). Ten
randomly selected clones of each sample were sequenced using
the T7 and T3 universal primers.
Mitochondria DNA Evaluation
Real-time PCR was performed using the 7300 Real-Time PCR
System (Applied Biosystems). Thematching primers and dye probe
for the MT-ND1 (Hs02596873_s1) and b-ACTIN (Hs00357333_g1)
were purchased from Applied Biosystems. Copy numbers were
quantified by RQ software (Applied Biosystems).
Metabolic Analyses
HDFs were transduced with CM retrovirus vectors as above. After
cultured for 12 days, the cells were used as dBAs. To assess glucose
consumption, culture supernatants of HDFs, un-stimulated dBAs,
and dBAs pre-stimulated with 1 mM isoproterenol (LKT Labora-
tories) for 2 hr were replaced by fresh complete medium. Before
and 24 hr after culture under the standard conditions, glucose
concentrations in the culture supernatants were measured by the
glucose B test (Wako). To determine glucose uptake, culture super-
natants of HDFs and dBAs were replaced by the Krebs Ringer
Phosphate HEPES buffer (1.2 mM KH2PO4, 1.2 mM MgSO4,
1.3 mM CaCl2, 118 mM NaCl, 5 mM KCl, and 30 mM HEPES
[pH 7.5]). Eighteenmin after addition of 1 mM insulin (Cell Science
& Technology Institute), 2DG was added to the culture to a final
concentration of 1 mM, and 30 min later, 2DG uptake was evalu-
ated using the 2-DGUptakeMeasurement Kit (CSR). Some aliquots
of cells were incubatedwith 1 mMAntimycin (Enzo Life Science) or
1 mM isoproterenol for 4 hr before the addition of insulin, whereas
other aliquots of cells were incubated with 200 mM phloretin
(Wako) for 2 min before the addition of 2DG. Oxygen consump-
tionwas determined using Extracellular Flux Analyzer XF96 instru-
ment (Seahorse Bioscience). Briefly, mitochondrial biogenesis was
profiled by serially adding perturbation agents, i.e., 2 mMoligomy-
cin (Sigma; cat no. 04876), 0.5 mM FCCP (carbonylcyanide-p-tri-
fluoromethoxyphenylhydrazone; Sigma; cat no. C2920), and
3 mM antimycin A (Sigma; cat no. A8674), and 1 mM rotenone
(Sigma; cat no. R8875) to the cells.
Transplantation
Every animal experiment was approved by the institutional
Animal Experiment Committee, and care of the animals was in
accordance with institutional guidelines. Male C57BL/6 and
KK-Ay/Tajcl mice (Shimizu Laboratory Suppliers) at 8 weeks of
age were anesthetized with an intraperitoneal injection of pento-
barbital. In iBA transplantation experiments, the iBAs in two
confluent 100-mm dishes were resuspended in 25 ml medium/
75 ml Matrigel (BD Bioscience) and subcutaneously transplanted
to the flank of syngenic mice. As control, cells were transduced
with GFP retroviral vector instead of Prdm16 retroviral vector
and transplanted to mice as above, whereas the other control
group was not transplanted. In dBA transplantation experiments,
dBAs that had been induced from MEF by PCL retroviral vector
transduction, and MEF that had been transduced with GFP retro-
viral vector as control, were transplanted to syngenic mice as
above.Reports j Vol. 5 j 569–581 j October 13, 2015 j ª2015 The Authors 579
Diet-Induced Obesity Mouse Model
Micewerehousedonhigh-fat diet (Quick Fat; CLEA Japan) or regular
chow (CE-2; CLEA Japan) as control. Diet composition (w/w %) of
the high-fat diet was as follows: 24.0% crude protein; 14.6% crude
fat; 2.7% crude fiber; 5.1%crude ash; 46.7%NFE; and 7.3%moisture
(Katakura et al., 2012). Total calorie of the high-fat diet was
415.1 kcal/100 g. The regular chow was composed of 24.9% (w/w)
crude protein, 4.6% crude fat, 4.1% crude fiber, 6.6% crude ash,
51.0% NFE, and 8.9% moisture with total calories of 344.9 kcal/
100 g. Any significant difference was not observed among the
amounts of food intake of all mouse groups fed high-fat diet during
the experimental periods in all experiments (Figure S7).
Thermography and Metabolic Analyses of Mice
Thermographic imagingwas obtainedusing a thermal imaging cam-
era (Fliar Systems). Serumlipidswere evaluatedusing theNEFACTest
(Wako), Triglyceride E Test (Wako), Phospholipids C Test (Wako),
HDL-cholesterol E Test (Wako), and Total Cholesterol E Test
(Wako). Blood glucose levels were measured using GluTest (Sanwa
Kagaku). For the oral glucose tolerance test, mice were administered
with 50 mg of glucose via a gastric catheter. Before and 30, 60, and
120 min after the administration, blood glucose was evaluated as
above. For the insulin-resistant test, mice were intraperitoneally
administered with 0.0125 U of insulin. Before and 30, 60, and
120 min after the administration, blood glucose was determined.
Statistical Analyses
Data are expressed as average ± SD. Data in each group distributed
normally, and variance was similar between the groups that were
statistically compared. Statistical significance was analyzed by
Student’s t test (two-sided). A value of p < 0.05 was considered sig-
nificant. No statistical analysis was used to predetermine sample
size. Experiments were performed in randomized and non-blind
fashion. No samples or animals were excluded from the analyses.
The data met the assumptions of the tests.
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